Related Experiment Video

Updated: Aug 9, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease

Harm H H Feringa1, Virginie H van Waning, Jeroen J Bax

  • 1Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands.

Journal of the American College of Cardiology
|March 21, 2006
PubMed

Insights

Certain cardiac medications significantly reduce long-term mortality in peripheral arterial disease (PAD) patients. Statins, beta-blockers, aspirin, and ACE inhibitors were associated with lower death risk in this study.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Peripheral arterial disease (PAD) is a significant risk factor for cardiovascular morbidity and mortality.
  • Current guidelines emphasize risk factor management and lifestyle changes for PAD patients.
  • The impact of cardiac medications on long-term outcomes in PAD is not well-defined.

Purpose of the Study:

  • To investigate the association between cardiac medication use and long-term mortality in patients diagnosed with peripheral arterial disease (PAD).

Main Methods:

  • Prospective observational cohort study involving 2,420 patients with PAD (ankle-brachial index <= 0.90).
  • Collected data on clinical risk factors and cardiac medication use.
  • Utilized propensity scores and Cox regression models to analyze the relationship between medication and all-cause mortality over a median follow-up of eight years.

Main Results:

  • Over eight years, 1,067 patients (44%) died.
  • After adjusting for risk factors and propensity scores, statins (HR 0.46), beta-blockers (HR 0.68), aspirin (HR 0.72), and ACE inhibitors (HR 0.80) were significantly linked to reduced mortality.
  • These findings were consistent across various patient demographics and comorbidities.

Conclusions:

  • Statins, beta-blockers, aspirin, and angiotensin-converting enzyme (ACE) inhibitors are associated with a reduced risk of long-term mortality in patients with peripheral arterial disease (PAD).
  • These findings support the use of these cardiac medications in the management of PAD patients to improve survival outcomes.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...